Call for Nominations for the 2009 C.A.R.E. Pharmacy Award

Eisai Inc. and the Alzheimer's Association Support Award to Recognize Critical
Role of Pharmacists in Alzheimer's Care

WOODCLIFF LAKE, N.J., June 1 /PRNewswire/ -- Eisai Inc., in coordination with
the Alzheimer's Association, calls on individuals with Alzheimer's disease and
their caregivers across America to nominate local pharmacists for the 2009
C.A.R.E. (Commitment to Alzheimer's. Recognition of Excellence.) Pharmacy
Award. This award recognizes the vital role that pharmacists play in helping
as many as 5.3 million Americans living with Alzheimer's disease and their 10
million caregivers.(1)

Now in its ninth year, the C.A.R.E. Pharmacy Award reflects Eisai's human
health care (hhc) mission, which regards patients and their families as the
most important participants in the health care process. The C.A.R.E. Pharmacy
Award is one way for people with the disease and caregivers to acknowledge the
extraordinary efforts of community pharmacists and their impact on the lives
of people affected by Alzheimer's disease.

"Alzheimer's is a disease that affects both patients and their caregivers, and
Eisai's commitment to the patient and caregiver communities is unwavering,"
said Cynthia Schwalm, President of Eisai Inc. "We recognize the integral role
that community pharmacists play in each patient's treatment and care,
providing ongoing monitoring, counseling and support. The C.A.R.E. Pharmacy
Award allows us to acknowledge their efforts and showcase best practices in
caregiving techniques. We are proud to be working with the Alzheimer's
Association to honor the extraordinary contributions of pharmacists who are
making a difference in the lives of people affected by Alzheimer's disease."

In addition to being recognized, the winning pharmacist's local Alzheimer's
Association chapter will receive a $1,500 donation for its vital support
programs. Another $1,500 donation will go to the Alzheimer's Association
chapters located in the areas from which the most nominations are submitted.

"The Alzheimer's Association is excited to partner again with Eisai to
recognize pharmacists who actively participate as part of the team of care
providers for those with Alzheimer's disease," said Elizabeth Gould, MSW,
director of quality care programs for the Alzheimer's Association. "We
commend pharmacists who take the time to build relationships with their
patients living with Alzheimer's and their caregivers, helping to educate them
about Alzheimer's disease and enhancing the support they receive."

How to Nominate a Pharmacist
Alzheimer's patients and caregivers can nominate pharmacists through September
2009 by visiting www.carepharmacyaward.com. To be eligible, nominees must be
licensed pharmacists involved in activities within the last year that have
helped people with Alzheimer's disease, and these activities must have had a
positive effect on patients and/or their families. A full description of the
award and nomination criteria can be found at www.carepharmacyaward.com.

The winning pharmacist will be selected in October from the nominee pool by a
panel of three judges. One judge is a director at the Alzheimer's
Association's national office. The other two judges are past winners of this
award. Each has spent more than 20 years improving the care of people with
Alzheimer's disease through educational, advocacy and caregiver support
programs.

About Eisai Inc.
Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., a
research-based human health care (hhc) company that discovers, develops and
markets products throughout the world. Eisai focuses its efforts in three
therapeutic areas: neurology, gastrointestinal disorders and oncology/critical
care. Established in 1995 and ranked among the top-20 U.S. pharmaceutical
companies (based on retail sales), Eisai Inc. began marketing its first
product in the United States in 1997 and has rapidly grown to become an
integrated pharmaceutical business with fiscal year 2008 (year ended March 31,
2009) sales of approximately $3.7 billion, including the results of the
acquisition of MGI PHARMA, INC.

Eisai Inc. employs approximately 1,900 people at its headquarters in Woodcliff
Lake, NJ, at its state-of-the-art pharmaceutical production and formulation
research and development facility in Research Triangle Park, NC, and in the
field. For more information about Eisai, please visit www.eisai.com.

About the Alzheimer's Association
The Alzheimer's Association is the leading voluntary health organization in
Alzheimer's research, care and support. Our mission is to eliminate
Alzheimer's disease through the advancement of research, provide and enhance
care and support for all affected, and reduce the risk of dementia through the
promotion of brain health. Our vision is a world without Alzheimer's. For
more information, visit www.alz.org.

Reference: 1. Alzheimer's Association. Alzheimer's Disease Facts and Figures.
2009:10,65.

SOURCE Eisai Inc.

Suzanne Grogan of Eisai Inc., +1-201-746-2083